Human Papillomavirus Immunity in Oropharyngeal Cancer: Time to Change the Game?

For the first time, human papillomavirus (HPV)–specific immunity has been linked directly to the beneficial prognosis of oropharyngeal squamous cell carcinoma (OPSCC). Those patients lacking HPV immunity fare much worse. These results harbor crucial implications for future management of HPV-driven OPSCC as well as for its definition. Clin Cancer Res; 24(3); 505–7. ©2017 AACR.

See related article by Welters et al., p. 634

http://ift.tt/2E0Xbef